Hartford Investment Management Co. boosted its position in MetLife, Inc. (NYSE:MET) by 0.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 264,475 shares of the company’s stock after buying an additional 607 shares during the period. Hartford Investment Management Co.’s holdings in MetLife were worth $11,751,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Jacobus Wealth Management Inc. bought a new position in shares of MetLife during the third quarter worth approximately $104,000. Carroll Financial Associates Inc. raised its position in shares of MetLife by 51.5% in the third quarter. Carroll Financial Associates Inc. now owns 2,625 shares of the company’s stock worth $116,000 after buying an additional 892 shares in the last quarter. ClariVest Asset Management LLC raised its position in shares of MetLife by 0.3% in the second quarter. ClariVest Asset Management LLC now owns 2,806 shares of the company’s stock worth $112,000 after buying an additional 8 shares in the last quarter. Edge Wealth Management LLC raised its position in shares of MetLife by 631.7% in the third quarter. Edge Wealth Management LLC now owns 3,000 shares of the company’s stock worth $133,000 after buying an additional 2,590 shares in the last quarter. Finally, Alpha Windward LLC raised its position in shares of MetLife by 2.5% in the third quarter. Alpha Windward LLC now owns 3,192 shares of the company’s stock worth $142,000 after buying an additional 79 shares in the last quarter. 74.82% of the stock is owned by hedge funds and other institutional investors.
MetLife, Inc. (NYSE:MET) opened at 52.91 on Friday. The company has a 50-day moving average of $53.88 and a 200 day moving average of $48.85. The firm has a market capitalization of $57.96 billion, a price-to-earnings ratio of 84.12 and a beta of 1.65. MetLife, Inc. has a one year low of $36.17 and a one year high of $58.09.
MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 1st. The company reported $1.28 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by $0.06. MetLife had a return on equity of 7.17% and a net margin of 1.30%. The firm earned $12.08 billion during the quarter, compared to the consensus estimate of $17.34 billion. During the same quarter in the previous year, the company earned $1.23 EPS. The business’s revenue was down 29.1% compared to the same quarter last year. On average, analysts anticipate that MetLife, Inc. will post $5.33 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 13th. Stockholders of record on Monday, February 6th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.02%. MetLife’s payout ratio is 262.30%.
MET has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of MetLife from a “sell” rating to a “hold” rating in a research report on Monday, October 17th. TheStreet raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Friday, October 28th. FBR & Co reissued a “buy” rating on shares of MetLife in a research note on Thursday, November 3rd. J P Morgan Chase & Co reissued a “buy” rating and issued a $51.00 target price on shares of MetLife in a research note on Friday, November 4th. Finally, Argus reissued a “buy” rating and issued a $54.00 target price on shares of MetLife in a research note on Tuesday, November 8th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $54.73.
In related news, EVP Peter M. Carlson sold 23,636 shares of the stock in a transaction dated Friday, December 23rd. The shares were sold at an average price of $54.32, for a total transaction of $1,283,907.52. Following the completion of the transaction, the executive vice president now owns 39,914 shares in the company, valued at $2,168,128.48. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Frans Hijkoop sold 14,997 shares of the stock in a transaction dated Thursday, December 1st. The shares were sold at an average price of $56.18, for a total transaction of $842,531.46. Following the transaction, the executive vice president now owns 70,560 shares of the company’s stock, valued at approximately $3,964,060.80. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.
MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/hartford-investment-management-co-boosts-stake-in-metlife-inc-met/1655571.html
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.